IL-6 serum levels predict severity and response to tocilizumab in COVID-19: An observational study
…, E Roy-Vallejo, A Marcos-Jiménez… - Journal of Allergy and …, 2021 - Elsevier
… Rodríguez-García MD b ∗ , Emilia Roy-Vallejo MD a , Ana Marcos-Jiménez MSc c , Santiago
Sánchez-Alonso MSc c , Carlos Fernández-Díaz MD b , Ana Alcaraz-Serna MD c , Tamara …
Sánchez-Alonso MSc c , Carlos Fernández-Díaz MD b , Ana Alcaraz-Serna MD c , Tamara …
COVID-19 severity associates with pulmonary redistribution of CD1c+ DCs and inflammatory transitional and nonclassical monocytes
…, A Sánchez-Azofra, A Marcos-Jiménez… - The Journal of …, 2020 - Am Soc Clin Investig
SARS-CoV-2 is responsible for the development of coronavirus disease 2019 (COVID-19)
in infected individuals, who can either exhibit mild symptoms or progress toward a life-…
in infected individuals, who can either exhibit mild symptoms or progress toward a life-…
Differential redistribution of activated monocyte and dendritic cell subsets to the lung associates with severity of COVID-19
…, S Sánchez-Alonso, AS Azofra, A Marcos-Jiménez… - MedRxiv, 2020 - medrxiv.org
The SARS-CoV-2 is responsible for the pandemic COVID-19 in infected individuals, who
can either exhibit mild symptoms or progress towards a life-threatening acute respiratory …
can either exhibit mild symptoms or progress towards a life-threatening acute respiratory …
Deregulated cellular circuits driving immunoglobulins and complement consumption associate with the severity of COVID‐19 patients
A Marcos‐Jiménez, S Sánchez‐Alonso… - European Journal of …, 2021 - Wiley Online Library
SARS‐CoV‐2 infection causes an abrupt response by the host immune system, which is largely
responsible for the outcome of COVID‐19. We investigated whether the specific immune …
responsible for the outcome of COVID‐19. We investigated whether the specific immune …
Detection of SARS-CoV-2 RNA in serum is associated with increased mortality risk in hospitalized COVID-19 patients
…, P Rodriguez-Cortes, L Esparcia, A Marcos-Jimenez… - Scientific Reports, 2021 - nature.com
COVID-19 has overloaded national health services worldwide. Thus, early identification of
patients at risk of poor outcomes is critical. Our objective was to analyse SARS-CoV-2 RNA …
patients at risk of poor outcomes is critical. Our objective was to analyse SARS-CoV-2 RNA …
Dasatinib reversibly disrupts endothelial vascular integrity by increasing non-muscle myosin II contractility in a ROCK-dependent manner
A Kreutzman, B Colom-Fernández, AM Jiménez… - Clinical Cancer …, 2017 - AACR
Purpose: Dasatinib is a short-acting dual ABL/SRC family tyrosine kinase inhibitor (TKI),
which is frequently used to treat chronic myeloid leukemia. Although very effective, patients …
which is frequently used to treat chronic myeloid leukemia. Although very effective, patients …
Dynamic assessment of interleukin‐6 during hemodialysis and mortality in coronavirus disease‐19
…, O Almería Gómez, A Marcos‐Jiménez… - Therapeutic …, 2021 - Wiley Online Library
The impact of the newly discovered severe acute respiratory syndrome coronavirus 2
causing coronavirus disease‐19 (COVID‐19) in hemodialysis patients remains poorly …
causing coronavirus disease‐19 (COVID‐19) in hemodialysis patients remains poorly …
Efficacy of short-course colchicine treatment in hospitalized patients with moderate to severe COVID-19 pneumonia and hyperinflammation: a randomized clinical trial
…, E Fernandez Carracedo, A Marcos-Jimenez… - Scientific Reports, 2022 - nature.com
Some patients with COVID-19 pneumonia develop an associated cytokine storm syndrome
that aggravates the pulmonary disease. These patients may benefit of anti-inflammatory …
that aggravates the pulmonary disease. These patients may benefit of anti-inflammatory …
CCR7 as a novel therapeutic target in t-cell PROLYMPHOCYTIC leukemia
…, M Espartero-Santos, A Marcos-Jimenez… - Biomarker …, 2020 - Springer
T-cell prolymphocytic leukemia (T-PLL) is a poor prognostic disease with very limited options
of efficient therapies. Most patients are refractory to chemotherapies and despite high …
of efficient therapies. Most patients are refractory to chemotherapies and despite high …
NFκB and NLRP3/NLRC4 inflammasomes regulate differentiation, activation and functional properties of monocytes in response to distinct SARS-CoV-2 proteins
…, M Calvet-Mirabent, A Marcos-Jimenez… - Nature …, 2024 - nature.com
Increased recruitment of transitional and non-classical monocytes in the lung during SARS-CoV-2
infection is associated with COVID-19 severity. However, whether specific innate …
infection is associated with COVID-19 severity. However, whether specific innate …
